retatrutide clinical trial results weight loss A new from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing and diabetes New GLP-1 obesity drug, retatrutide,
Pay in 4 interest-free payments of $7.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20





















